(Bloomberg) — A 15-minute Covid test from Abbott Laboratories that will be priced at just $5 has been granted emergency authorization for use in the U.S., a breakthrough that could ease the bottleneck that has crimped much of the nation’s testing capacity.The company’s shares climbed 8.7% to $112.91 at 9:57 a.m. in New York trading. The product, dubbed BinaxNOW, works without relying on laboratory equipment at a time when labs can take as long as two weeks to produce results. It uses a nasal swab and a small reactive card, and it can be administered by a range of health-care …read more
Source:: Yahoo Finance
